← SynDRA
LEVETIRACETAM
SynDRA canonical compound SYN0005031 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · Rx/OTC |
|---|
| Primary target(s) | SV2A |
|---|
| Mechanism of action | Calcium channel blocker |
|---|
| Indication | seizures |
|---|
| Disease area | neurology/psychiatry |
|---|
All known targets
- SV2A
- CACNA1B
- SCN1A
- CA1
- CACNA1G
- HTR3A
- Sv2a
Mechanisms of action (all sources)
- Calcium channel blocker
- SV2A MODULATOR
- Synaptic vesicle glycoprotein 2A modulator
- CACNA1B BLOCKER
- Voltage-gated N-type calcium channel alpha-1B subunit blocker
- HTR3A ANTAGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- CA4
- CA9
- CA6
- CA5B
- CA5A
- CA3
- CA2
- CA14
- CA13
- CA12
- CA7
- MLNR
- NPY1R
- MC3R
- NR3C1
- OPRD1
- OPRK1
- MAOA
- KDR
- KCNH2
- HTR2C
- HTR2B
- OPRM1
- HTR2A
- HTR1A
- HRH3
- NR1I2
- ABCB1
- HRH1
- SCN5A
- SLC6A4
- SLC6A3
- SLC6A2
- SLC47A2
- SLC47A1
- SLC29A1
- SAMHD1
- PDE3A
- PTGS2
- PTGS1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Anticonvulsants
- Central Nervous System Agents
- Nootropic Agents
ATC classes
Cross-references
Synonyms
- ELEPSIA XR
- Elepsia
- KEPPRA
- KEPPRA XR
- Keppra
- LEVETIRACETAM IN SODIUM CHLORIDE
- Roweepra
- SPRITAM
- Spritam
- keppra
- matever
- (-)-Levetiracetam
- levroxa
- UCB 6474
- Levetiracetam accord
- Levetiracetam actavis
- Levetiracetam hospira
- Levetiracetam sun
- Levetiracetam teva
- Levetiracetame
- AGB-101
- N03AX14
- NSC-760119
- UCB-22059
- UCB-L059
- Desitrend
- Elepsia xr
- Keppra xr
- Levetiracetam actavis group
- Levetiracetam in sodium chloride
- Levetiracetam ratiopharm
- Matever
- Keppra XR
- Levetiracetamum
- UCB-L 059
- SIB-S1
- UNII-44YRR34555
Reported adverse events
- Alopecia
- Amnesia
- Vertigo
- Infection
- Diplopia
- Cough
- Somnolence
- Asthenia
- Depression
- Agitation
- Constipation
- Dizziness
Look up LEVETIRACETAM in the interactive SynDRA portal →